Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 2, 2026British Journal of Hospital MedicineOpen Access

Idiopathic Pulmonary Fibrosis: An Overview

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJames MayGJGisli Jenkins

Discussion

Loading...

Member takes

Overview

Overview reports disease mechanisms and management strategies in idiopathic pulmonary fibrosis, highlighting key insights.

Key Points

  • To provide a comprehensive overview of idiopathic pulmonary fibrosis, its definitions, mechanisms, and management.
  • Review of definitions and epidemiology of IPF.
  • Analysis of pathobiology and current understanding of disease mechanisms.
  • Summary of licensed treatments and emerging therapies.
  • Evaluation of lung transplant outcomes in IPF patients.
  • Incidence of IPF is increasing, raising public health concerns.
  • Poor prognosis averages 3-5 years post-diagnosis due to respiratory failure.
  • Limited existing therapies can only slow disease progression, not reverse it.
  • Lung transplant significantly improves both duration and quality of life.

Cite This Study

May et al. (2026) studied this question.

synapsesocial.com/papers/69a52dd3f1e85e5c73bf101bhttps://doi.org/10.31083/bjhm50844
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan2013 · 561 citations
  2. 2Nintedanib in Progressive Fibrosing Interstitial Lung Diseases2019 · 2,442 citations
  3. 3Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis2009 · 118 citations
  4. 4Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis2022 · 71 citations
  5. 5Virus infection induced pulmonary fibrosis2021 · 163 citations